133 related articles for article (PubMed ID: 11418471)
1. Defective binding of factor XI-N248 to activated human platelets.
Sun MF; Baglia FA; Ho D; Martincic D; Ware RE; Walsh PN; Gailani D
Blood; 2001 Jul; 98(1):125-9. PubMed ID: 11418471
[TBL] [Abstract][Full Text] [Related]
2. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
Zivelin A; Ogawa T; Bulvik S; Landau M; Toomey JR; Lane J; Seligsohn U; Gailani D
J Thromb Haemost; 2004 Oct; 2(10):1782-9. PubMed ID: 15456490
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids in the factor XI apple 3 domain required for activation of factor IX.
Sun MF; Zhao M; Gailani D
J Biol Chem; 1999 Dec; 274(51):36373-8. PubMed ID: 10593931
[TBL] [Abstract][Full Text] [Related]
4. RETRACTED: The glycoprotein Ib-IX-V complex mediates localization of factor XI to lipid rafts on the platelet membrane.
Baglia FA; Shrimpton CN; López JA; Walsh PN
J Biol Chem; 2003 Jun; 278(24):21744-50. PubMed ID: 12517745
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
Baglia FA; Walsh PN
Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
[TBL] [Abstract][Full Text] [Related]
6. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain.
Ho DH; Baglia FA; Walsh PN
Biochemistry; 2000 Jan; 39(2):316-23. PubMed ID: 10630991
[TBL] [Abstract][Full Text] [Related]
7. The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface.
Ho DH; Badellino K; Baglia FA; Sun MF; Zhao MM; Gailani D; Walsh PN
J Biol Chem; 2000 Aug; 275(33):25139-45. PubMed ID: 10823824
[TBL] [Abstract][Full Text] [Related]
8. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
[TBL] [Abstract][Full Text] [Related]
9. RETRACTED: Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.
Baglia FA; Badellino KO; Li CQ; Lopez JA; Walsh PN
J Biol Chem; 2002 Jan; 277(3):1662-8. PubMed ID: 11696542
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.
Walsh PN; Sinha D; Koshy A; Seaman FS; Bradford H
Blood; 1986 Jul; 68(1):225-30. PubMed ID: 3487355
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency.
Salomon O; Zivelin A; Livnat T; Dardik R; Loewenthal R; Avishai O; Steinberg DM; Rosove MH; O'Connell N; Lee CA; Seligsohn U
Blood; 2003 Jun; 101(12):4783-8. PubMed ID: 12586617
[TBL] [Abstract][Full Text] [Related]
12. Thrombin activates factor XI on activated platelets in the absence of factor XII.
Oliver JA; Monroe DM; Roberts HR; Hoffman M
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):170-7. PubMed ID: 9888880
[TBL] [Abstract][Full Text] [Related]
13. A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
Miller TN; Sinha D; Baird TR; Walsh PN
Biochemistry; 2007 Dec; 46(50):14450-60. PubMed ID: 18020374
[TBL] [Abstract][Full Text] [Related]
14. Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting.
Martincic D; Zimmerman SA; Ware RE; Sun MF; Whitlock JA; Gailani D
Blood; 1998 Nov; 92(9):3309-17. PubMed ID: 9787168
[TBL] [Abstract][Full Text] [Related]
15. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet.
Baglia FA; Shrimpton CN; Emsley J; Kitagawa K; Ruggeri ZM; López JA; Walsh PN
J Biol Chem; 2004 Nov; 279(47):49323-9. PubMed ID: 15375170
[TBL] [Abstract][Full Text] [Related]
16. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.
Kravtsov DV; Wu W; Meijers JC; Sun MF; Blinder MA; Dang TP; Wang H; Gailani D
Blood; 2004 Jul; 104(1):128-34. PubMed ID: 15026311
[TBL] [Abstract][Full Text] [Related]
17. Identification of a factor IX binding site on the third apple domain of activated factor XI.
Sun Y; Gailani D
J Biol Chem; 1996 Nov; 271(46):29023-8. PubMed ID: 8910554
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.
Baglia FA; Walsh PN
J Biol Chem; 2000 Jul; 275(27):20514-9. PubMed ID: 10781579
[TBL] [Abstract][Full Text] [Related]
19. Comparative interactions of factor IX and factor IXa with human platelets.
Ahmad SS; Rawala-Sheikh R; Walsh PN
J Biol Chem; 1989 Feb; 264(6):3244-51. PubMed ID: 2492533
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1995 Mar; 270(12):6734-40. PubMed ID: 7896818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
